Aurobindo Pharma Ltd step-down subsidiary company, Aurolife Pharma LLC., has received a final approval from the US Food & Drug Administration to manufacture and market Diclofenac Sodium Topical Solution USP, 2%.
Alembic Pharmaceuticals Limited has received final approval from the US Food & Drug Administration for its Abbreviated New Drug Application, Diclofenac Sodium Topical Solution USP, 2% w/w.